| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Atopic dysfunction and risk of central nervous system tumours in children
|
Harding, N.J.
|
|
2008
|
44 |
1 |
p. 92-99
8 p.
|
artikel
|
| 2 |
Calendar
|
|
|
2008
|
44 |
1 |
p. I-IV
nvt p.
|
artikel
|
| 3 |
Cancer prevalence in France: Time trend, situation in 2002 and extrapolation to 2012
|
Colonna, Marc
|
|
2008
|
44 |
1 |
p. 115-122
8 p.
|
artikel
|
| 4 |
Common variants of DNA repair genes and malignant melanoma
|
Dębniak, T.
|
|
2008
|
44 |
1 |
p. 110-114
5 p.
|
artikel
|
| 5 |
Design and conduct of phase II studies of targeted anticancer therapy: Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT)
|
Booth, Christopher M.
|
|
2008
|
44 |
1 |
p. 25-29
5 p.
|
artikel
|
| 6 |
Editorial board
|
|
|
2008
|
44 |
1 |
p. ii-
1 p.
|
artikel
|
| 7 |
Ejc News, Issue 1, 2008
|
|
|
2008
|
44 |
1 |
p. 1-5
5 p.
|
artikel
|
| 8 |
Endpoints and other considerations in phase I studies of targeted anticancer therapy: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT)
|
Booth, Christopher M.
|
|
2008
|
44 |
1 |
p. 19-24
6 p.
|
artikel
|
| 9 |
ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer
|
Kim, Min Kyoung
|
|
2008
|
44 |
1 |
p. 54-60
7 p.
|
artikel
|
| 10 |
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer
|
Marabese, Mirko
|
|
2008
|
44 |
1 |
p. 131-141
11 p.
|
artikel
|
| 11 |
Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients
|
Quinn, Barry
|
|
2008
|
44 |
1 |
p. 61-72
12 p.
|
artikel
|
| 12 |
How to assess anti-tumour efficacy by imaging techniques
|
Gwyther, Stephen J.
|
|
2008
|
44 |
1 |
p. 39-45
7 p.
|
artikel
|
| 13 |
Identification of a novel, functional role for S100A13 in invasive lung cancer cell lines
|
Pierce, A.
|
|
2008
|
44 |
1 |
p. 151-159
9 p.
|
artikel
|
| 14 |
Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes
|
Rakha, Emad A.
|
|
2008
|
44 |
1 |
p. 73-83
11 p.
|
artikel
|
| 15 |
Mesothelin targeted cancer immunotherapy
|
Hassan, Raffit
|
|
2008
|
44 |
1 |
p. 46-53
8 p.
|
artikel
|
| 16 |
Morbidity and mortality in relation to smoking among women and men of Chinese ethnicity: The Singapore Chinese Health Study
|
Shankar, Anoop
|
|
2008
|
44 |
1 |
p. 100-109
10 p.
|
artikel
|
| 17 |
Protective effect from solar exposure, risk of an ecological fallacy
|
Grimsrud, Tom K.
|
|
2008
|
44 |
1 |
p. 16-18
3 p.
|
artikel
|
| 18 |
Recommended changes to oncology clinical trial design: Revolution or evolution?
|
Ratain, Mark J.
|
|
2008
|
44 |
1 |
p. 8-11
4 p.
|
artikel
|
| 19 |
Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice
|
Bueno, Lorea
|
|
2008
|
44 |
1 |
p. 142-150
9 p.
|
artikel
|
| 20 |
Tamoxifen: Catalyst for the change to targeted therapy
|
Jordan, V. Craig
|
|
2008
|
44 |
1 |
p. 30-38
9 p.
|
artikel
|
| 21 |
The α1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-κB signalling to induce breast cancer cell apoptosis
|
Hui, Hongxiang
|
|
2008
|
44 |
1 |
p. 160-166
7 p.
|
artikel
|
| 22 |
The effect of solar UVB doses and vitamin D production, skin cancer action spectra, and smoking in explaining links between skin cancers and solid tumours
|
Grant, William B.
|
|
2008
|
44 |
1 |
p. 12-15
4 p.
|
artikel
|
| 23 |
The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics
|
Awada, Ahmad
|
|
2008
|
44 |
1 |
p. 84-91
8 p.
|
artikel
|
| 24 |
The strength of European oncology
|
Smyth, John F.
|
|
2008
|
44 |
1 |
p. 6-7
2 p.
|
artikel
|
| 25 |
Thymic epithelial tumours: A population-based study of the incidence, diagnostic procedures and therapy
|
de Jong, Wouter K.
|
|
2008
|
44 |
1 |
p. 123-130
8 p.
|
artikel
|
Tijdschrift beschrijving